JNJ vs SPEGR
Johnson & Johnson (JNJ) versus Silver Pegasus Acquisition Corp Rights. (SPEGR) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Silver Pegasus Acquisition Corp Rights. (SPEGR) common stock listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
SPEGR does not have a complete income-statement cache yet.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. SPEGR currently screens at market cap $0.
Not investment advice. Open the JNJ and SPEGR stock pages for the full models.
Not investment advice.